Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Smoking Cessation With Varenicline (Champix) and Integrated Voice Response Technology (IVR)

NCT00832806 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT00832806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00832806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Smoking Cessation With Varenicline (Champix) and Integrated Voice Response Technology (IVR)
Lead sponsor
University of British Columbia
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2008
Completion date
November 30, 2011
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

additional, effective methods to stop smoking